Abstract:Introduction: Patients who are considered high-risk for choledocholithiasis after biochemical testing and abdominal ultrasound (AUS) are recommended to undergo endoscopic retrograde cholangiopancreatography (ERCP) with others to receive less invasive tests. The aim of the study is to determine whether high-risk patients by ASGE guidelines or other factors can accurately identify those with choledocholithiasis.Table 1: Diagnostic Performance of ASGE High-Risk Group and Other Test Characteristics in Patients with Suspected Choledocholithiasis ( N =2,726)Methods: Consecutive patients hospitalized (1/2011-12/2013) with suspected choledocholithiasis who received biochemical testing, AUS and definitive testing for choledocholithiasis (magnetic resonance cholangiopancreatography (MRCP), endoscopic ultrasound (EUS), ERCP, interventional radiology procedure and/or intraoperative cholangiogram (IOC)) at Sir Run Run Shaw Hospital were retrospectively identified. Patients with choledocholithiasis on AUS, bilirubin >4mg/dL, bilirubin >1.8mg/dL + dilated common bile duct (CBD) (>8mm and >6mm with or without prior cholecystectomy) and/or suspected cholangitis (presenting fever and/or leukocytosis) were considered high-risk per ASGE guidelines. Final diagnosis was based on choledocholithiasis identified on definitive testing. Results: Mean age of 2,726 patients with suspected choledocholithiasis was 55+15 yrs, 1,179 (43%) were male and 216 (8%) had prior cholecystectomy. On definitive testing (MRCP in 2,441 (90%), EUS in 69 (3%), interventional radiology procedure in 2, ERCP in 643 (23%), IOC in 189 (7%)), 1,076 (39%) patients had choledocholithiasis. A higher proportion of patients meeting ASGE high-risk criteria compared to other groups (770/1,271 (61%) vs. 306/1,455 (21%); OR=5.8, 95%CI 4.9-6.8) had confirmed choledocholithiasis. Diagnostic performance of test characteristics is shown (Table). On multivariate analysis, choledocholithiasis on AUS (AOR=17.4, 95%CI 12.6-23.9), bilirubin >4mg/dL (AOR=3.0, 95%CI 2.2-4.1) and bilirubin 1.8-4mg/dL (AOR=1.8, 95%CI 1.4-2.4) compared to < 1.8mg/dL and CBD dilation (AOR=1.8, 95%CI 1.5-2.2) increased the likelihood of choledocholithiasis. Conclusion: In patients with suspected choledocholithiasis, the specificity of high-risk group categorized by ASGE guidelines was suboptimal. Combination of factors that include choledocholithiasis on AUS and bilirubin >4mg/dL with or without CBD dilation had high specificities of >90% and moderate to high positive likelihood ratios. A revised algorithm with more stringent criteria may improve patient selection and reduce the risk of diagnostic ERCP.

Application Value of Radionuclide Hepatobiliary Imaging and Ultrasonography in Patients Undergoing Gallbladder-Preserving Surgery

Suboptimal Specificity of Asge High-Risk Group in Evaluation of Patients with Suspected Choledocholithiasis

Accuracy of ASGE High-Risk Criteria in Evaluation of Patients with Suspected Common Bile Duct Stones

Laparoscopic Cholecystectomy Combined with Intraoperative Cholangiography and Endoscopic Sphincterotomy for the Treatment of Choledocholithiasis

Repeat ultrasonography and MRCP after the pain had subsided in patients who presented with acute abdomen caused by a single common bile duct stone

Intraoperative ERCP and endoscopic sphincterotomy combined with laparoscopic cholecystectomy for treatment of cholelithiasis with choledocholithiasis

A Research on Cholecystitis and Cholelithiasis by Radionuclide Hepatobiliary Imaging

Rational option and evaluation of imaging assessment methods before cholecystectomy

Applicationof selected via cystic duct cholangiography in emergency laparoscopic cholecystectomy

Value of enhanced MSCT in the diagnosis of gallbladder perforation

Clinical analysis of ultrasound guided percutaneous transhepatic gallbladder drainage in treating high-risk patients with acute moderate or severe cholecystitis

The Application of Contrast-Enhanced Ultrasonography in Differential Diagnosis of Gallbladder Lesions

Ultrasound-guided double-tract percutaneous cholecystostomy combined with a choledochoscope for performing cholecystolithotomies in high-risk surgical patients

Value of SonoVue-enhanced grey scale ultrasonography for differential diagnosis of benign and malignant neoplasms of the gallbladder

Comparison of Cholecystectomy and Gallbladder-Preserving Cholecystolithotomy in Treatment of Gallstones

Application of Contrast Enhanced Ultrasound in Gallbladder Lesion: is It Helpful to Improve the Diagnostic Capabilities?

Contrast-enhanced ultrasound in differential diagnosis of gallbladder cancer from xanthogranulomatous chole-cystitis

Minimally-invasive Operation with Gallbladder Preserved by Choledochoscopy in 33 Cases of Cholecystolithiasis with Nonvisualization of Gall Bladder in Preoperative ECT

5-year retrospective analysis of laparoscopic combined choledochoscopic gallbladder-preserving cholelithotomy: with a report of 360 cases

[Biological significance and activity of the complement system].

Ultrasonographic diagnosis of biliary obstruction after liver transplantation